Aptose Biosciences Inc. (APTO)
NASDAQ: APTO
· Real-Time Price · USD
1.71
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM
Aptose Biosciences Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 4.7M | 6.15M | n/a | 8.33M | 7.35M | 9.25M | 15.72M | 8.4M | 22.76M | 36.97M | 27.99M | 40.03M | 36.99M | 39.11M | 75.09M | 83.34M | 87.08M |
Short-Term Investments | n/a | n/a | n/a | n/a | 1.98M | n/a | 2M | 14.91M | 12.96M | 9.99M | 27.4M | 22.38M | 32.52M | 40.01M | 20.01M | 20M | 25M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 317K | 1.13M | 1.36M | 593K | 674K | 600K | 261K | 217K | 162K | 257K | 346K | 121K | 101K | 133K | 131K | 141K | 116K |
Total Current Assets | 6.97M | 9.53M | 10.23M | 10.16M | 11.82M | 11.89M | 19.67M | 25.26M | 37.93M | 49.52M | 56.58M | 64.19M | 71.87M | 81.74M | 96.27M | 105.31M | 114.14M |
Property-Plant & Equipment | 498K | 597K | 694K | 790K | 975K | 1.09M | 1.21M | 1.32M | 1.4M | 1.51M | 471K | 612K | 729K | 788K | 932K | 906K | 1.05M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 498K | 597K | 694K | 790K | 975K | 1.09M | 1.21M | 1.32M | 1.4M | 1.51M | 471K | 612K | 729K | 788K | 932K | 906K | 1.05M |
Total Assets | 7.47M | 10.13M | 10.93M | 10.95M | 12.8M | 12.99M | 20.88M | 26.57M | 39.33M | 51.03M | 57.05M | 64.81M | 72.6M | 82.53M | 97.2M | 106.21M | 115.19M |
Account Payables | 2.39M | 1.26M | 1.83M | 7.11M | 2.42M | 3.49M | 2.81M | 3.5M | 5.52M | 6.33M | 2.42M | 2.39M | 1.14M | 1.7M | 1.63M | 2.91M | 1.61M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 530K |
Other Current Liabilities | n/a | n/a | n/a | n/a | 8.18M | 6.85M | 50K | 6.44M | 5.41M | 3.36M | 5.7M | 5.15M | 4.6M | 3.87M | 4.45M | 2.79M | 1.65M |
Total Current Liabilities | 6.32M | 4.46M | 9.76M | 12.71M | 12.14M | 15.27M | 12.38M | 11.97M | 12.42M | 12.28M | 10.23M | 9.31M | 7.31M | 8.17M | 8.3M | 7.71M | 5.37M |
Long-Term Debt | 8.46M | 10.02M | 10M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 8.54M | 10.21M | 10.3M | 414K | 520K | 621K | 720K | 817K | 918K | 1M | 1K | 3K | 10K | 115K | 218K | 321K | 420K |
Total Liabilities | 14.86M | 14.67M | 20.06M | 13.13M | 12.66M | 15.89M | 13.1M | 12.79M | 13.34M | 13.29M | 10.23M | 9.31M | 7.32M | 8.29M | 8.52M | 8.03M | 5.79M |
Total Debt | 8.98M | 10.64M | 10.72M | 818K | 919K | 1.01M | 1.11M | 1.2M | 1.22M | 1.3M | 271K | 401K | 529K | 574K | 700K | 829K | 950K |
Common Stock | 459.77M | 457.4M | 452.3M | 452.29M | 450.49M | 444.81M | 443.94M | 439.1M | 437.95M | 437.52M | 437.47M | 437.44M | 437.41M | 437.39M | 429.8M | 429.8M | 429.65M |
Retained Earnings | -546.51M | -540.97M | -539.38M | -532.43M | -525.18M | -515.54M | -503.58M | -492.13M | -478.01M | -464.33M | -454.33M | -444.55M | -433.99M | -422.51M | -398.18M | -386.85M | -373.38M |
Comprehensive Income | -4.32M | -4.32M | -4.32M | -4.32M | -4.32M | -4.32M | -4.32M | -4.32M | -4.31M | -4.32M | -4.33M | -4.35M | -4.32M | -4.32M | -4.32M | -4.32M | -4.32M |
Shareholders Equity | -7.39M | -4.54M | -9.13M | -2.18M | 137K | -2.9M | 7.78M | 13.79M | 25.99M | 37.74M | 46.81M | 55.49M | 65.28M | 74.24M | 88.68M | 98.19M | 109.41M |
Total Investments | n/a | n/a | n/a | n/a | 1.98M | n/a | 2M | 14.91M | 12.96M | 9.99M | 27.4M | 22.38M | 32.52M | 40.01M | 20.01M | 20M | 25M |